It is thought that growth hormones, particularly insulin-like growth factor-1 (IGF-1), which influences promotion of cell proliferation and bone growth, may play a role in determining height (and breast density) in premenopausal women, which in turn increases breast cancer risk [40,41]. This evidence concerns the gene GH1 and breast carcinoma.